Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Evidence Based Reports
Updated 8/20/08
Updated 8/20/08
Recently Posted: Atypical Antipsychotics Report
 
DERP Reports and Key Questions
 
 
 HRC Report
 Executive Summary
Angiotensin II Receptor Antagonists or AIIRA
Antidepressants
Antiemetics or NAE
 
Antiepileptic or AP
Attention Deficit Hyperactivity Disorder or ADHD
Atypical Antipsychotics
Autism or ASD  
 
 
Beta 2 Agonists or B2  
Beta Blocker or BB
Calcium Channel Blockers or CCB
Combination Products for Type 2 DM & Hyperlipidemia or FDCP
Hormone Replacement Therapy - HRT
Inhaled Corticosteroid or ICS
Insomnia
Long-acting Analgesics for Non-cancer Pain or OPIOID
Multiple Sclerosis or MS
Newer Antiplatelet or AP
Neuropathic Pain  
Non-steroidal Anti-inflammatory Drugs or NSAIDS
Obesity, Surgical  
Obesity, Medical
Oral Hypoglycemics or OH
Over Active Bladder or OAB
Peginterferons for Hepatitis C  
Proton Pump Inhibitor or PPI
Skeletal Muscle Relaxers or SMR
STATIN
Targeted Immune Modulators or TIM
Thiazolidinediones or TZD
TRIPTAN
 


 

 
Page updated: August 20, 2008

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.